Cytokinetics (CYTK) Other Non-Current Liabilities (2016 - 2024)
Historic Other Non-Current Liabilities for Cytokinetics (CYTK) over the last 9 years, with Q1 2024 value amounting to $2000.0.
- Cytokinetics' Other Non-Current Liabilities fell 9976.11% to $2000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $2000.0, marking a year-over-year decrease of 9976.11%. This contributed to the annual value of $186000.0 for FY2023, which is 8218.39% down from last year.
- Latest data reveals that Cytokinetics reported Other Non-Current Liabilities of $2000.0 as of Q1 2024, which was down 9976.11% from $186000.0 recorded in Q4 2023.
- Cytokinetics' Other Non-Current Liabilities' 5-year high stood at $174.8 million during Q3 2021, with a 5-year trough of $2000.0 in Q1 2024.
- Moreover, its 5-year median value for Other Non-Current Liabilities was $2.3 million (2022), whereas its average is $62.1 million.
- Its Other Non-Current Liabilities has fluctuated over the past 5 years, first soared by 1702.56% in 2020, then tumbled by 9976.11% in 2024.
- Over the past 5 years, Cytokinetics' Other Non-Current Liabilities (Quarter) stood at $160.4 million in 2020, then tumbled by 97.22% to $4.5 million in 2021, then crashed by 76.58% to $1.0 million in 2022, then crashed by 82.18% to $186000.0 in 2023, then plummeted by 98.92% to $2000.0 in 2024.
- Its last three reported values are $2000.0 in Q1 2024, $186000.0 for Q4 2023, and $408000.0 during Q3 2023.